ADAR1 Capital Management, LLC 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 9:04 pm Sale | 2024-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | ADAR1 Capital Management, LLC | 298,955 4.910% | -181,476 (-37.77%) | Filing |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | Kala Pharmaceuticals, Inc. KALA | ADAR1 Capital Management, LLC | 480,431 9.990% | 480,431 (New Position) | Filing |